Leukocyte-specific protein 1 (LSP1): A regulator of leukocyte emigration in inflammation

Immunologic Research

Volumn 35, Issue 1-2, 2006, Pages 65-73

  Jongstra Bilen, Jenny ^a,c,d   Jongstra, Jan ^b,c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Cytoskeleton; Endothelial cells; F actin; Inflammation; Leukocytes; LSP1; Mac 1; MAPKAPKinase2; Neutrophils; Transmigration

Indexed keywords

INTEGRIN; LEUKOCYTE SPECIFIC PROTEIN 1; PROTEIN; UNCLASSIFIED DRUG;

CYTOSKELETON; HUMAN; INFLAMMATION; LEUKOCYTE MIGRATION; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; PROTEIN FUNCTION; REVIEW;

EID: 33749586461     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/IR:35:1:65     Document Type: Review

References (51)

1. Downey GP: Mechanisms of leukocyte motility and chemotaxis. Curr Opin Immunol 1994;6:113-124.
2. Mitchison TJ, Cramer LP: Actin-based cell motility and cell locomotion. Cell 1996;84:371-379.
3. Granger DN, Kubes P: The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion. J Leukoc Biol 1994;55:662-675.
4. Greenwood JA, Murphy-Ullrich JE: Signaling of de-adhesion in cellular regulation and motility. Microsc Res Tech 1998;43:420-432.
5. Gumbiner BM: Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 1996;84:345-357.
6. Cox EA, Huttenlocher A: Regulation of integrin-mediated adhesion during cell migration. Microsc Res Tech 1998;43:412-419.
7. Lauffenburger DA, Horwitz AF: Cell migration: a physically integrated molecular process. Cell 1996;84: 359-369.
8. Jongstra-Bilen J, Misener VL, Wang C, et al: LSP1 modulates leukocyte populations in resting and inflamed peritoneum. Blood 2000;96:1827-1835.
9. Wang C, Hayashi H, Harrison R, et al: Modulation of Mac-1 (CD11b/CD18)-mediated adhesion by the leukocyte-specific protein 1 is key to its role in neutrophil polarization and chemotaxis. J Immunol 2002;169:415-423.
10. Jongstra J, Tidmarsh GF, Jongstra-Bilen J, Davis MM: A new lymphocyte-specific gene which encodes a putative Ca2+-binding protein is not expressed in transformed T lymphocyte lines. J Immunol 1988;141: 3999-4004.
11. Kadiyala RK, McIntyre BW, Krensky AM: Molecular cloning and characterization of WP34, a phosphorylated human lymphocyte differentiation and activation antigen. Eur J Immunol 1990;20:2417-2423.
12. Klein DP, Jongstra-Bilen J, Ogryzlo K, Chong R, Jongstra J: Lymphocyte-specific Ca2+-binding protein LSP1 is associated with the cytoplasmic face of the plasma membrane. Mol Cell Biol 1989;9:3043-3048.
13. Jongstra-Bilen J, Young AJ, Chong R, Jongstra J: Human and mouse LSP1 genes code for highly conserved phosphoproteins. J Immunol 1990;144:1104-1110.
14. Jongstra J, Ittel ME, Iscove NN, Brady G: The LSP1 gene is expressed in cultured normal and transformed mouse macrophages. Mol Immunol. 1994;31:1125-1131.
15. Li Y, Guerrero A, Howard TH: The actin-binding protein, lymphocyte-specific protein 1, is expressed in human leukocytes and human myeloid and lymphoid cell lines. J Immunol 1995;155:3563-3569.
16. Pulford K, Jones M, Banham AH, Haralambieva E, Mason DY: Lymphocyte-specific protein 1: a specific marker of human leucocytes. Immunology 1999;96: 262-271.
17. Liu L, Cara DC, Kaur J, et al: LSP1 is an endothelial gatekeeper of leukocyte transendothelial migration. J Exp Med 2005;201:409-418.
18. Huang CK, Zhan L, Ai Y, Jongstra J: LSP1 is the major substrate for mitogen-activated protein kinase-activated protein kinase 2 in human neutrophils. J Biol Chem 1997;272:17-19.
19. Hannigan M, Zhan L, Ai Y, Huang CK: Leukocyte-specific gene 1 protein (LSP1) is involved in chemokine KC-activated cytoskeletal reorganization in murine neutrophils in vitro. J Leukoc Biol 2001;69:497-504.
20. Klein DP, Galea S, Jongstra J: The lymphocyte-specific protein LSP1 is associated with the cytoskeleton and co-caps with membrane IgM. J Immunol 1990;145: 2967-2973.
21. Jongstra-Bilen J, Janmey PA, Hartwig JH, Galea S, Jongstra J: The lymphocyte-specific protein LSP1 binds to F-actin and to the cytoskeleton through its COOH-terminal basic domain. J Cell Biol 1992;118: 1443-1453.
22. Howard TH, Hartwig J, Cunningham C: Lymphocyte-specific protein 1 expression in eukaryotic cells reproduces the morphologic and motile abnormality of NAD 47/89 neutrophils. Blood 1998;91:4786-4795.
23. Zhang Q, Li Y, Howard TH: Human lymphocyte-specific protein 1, the protein overexpressed in neutrophil actin dysfunction with 47-kDa and 89-kDa protein abnormalities (NAD 47/89), has multiple F-actin binding domains. J Immunol 2000;165:2052-2058.
24. Wong MJ, Malapitan IA, Sikorski BA, Jongstra J: A cell-free binding assay maps the LSP1 cytoskeletal binding site to the COOH-terminal 30 amino acids. Biochim Biophys Acta 2003;1642:17-24.
25. Cao MY, Shinjo F, Heinrichs S, Soh JW, Jongstra-Bilen J, Jongstra J: Inhibition of anti-IgM-induced translocation of protein kinase C beta I inhibits ERK2 activation and increases apoptosis. J Biol Chem 2001;276:24506-24510.
26. Coates TD, Torkildson JC, Torres M, Church JA, Howard TH: An inherited defect of neutrophil motility and microfilamentous cytoskeleton associated with abnormalities in 47-Kd and 89-Kd proteins. Blood 1991;78:1338-1346.
27. Li Y, Zhang Q, Aaron R, Hilliard L, Howard TH: LSP1 modulates the locomotion of monocyte-differentiated U937 cells. Blood 2000;96:1100-1105.
28. Howard T, Li Y, Torres M, Guerrero A, Coates T: The 47-kD protein increased in neutrophil actin dysfunction with 47- and 89-kD protein abnormalities is lymphocyte-specific protein. Blood 1994;83:231-241.
29. Southwick FS, Dabiri GA, Stossel TP: Neutrophil actin dysfunction is a genetic disorder associated with partial impairment of neutrophil actin assembly in three family members. J Clin Invest 1988;82:1525-1531.
30. Huttenlocher A, Sandborg RR, Horwitz AF: Adhesion in cell migration. Curr Opin Cell Biol 1995;7:697-706.
31. Taborda CP, Casadevall A: CR3 (CD11b/CD18) and CR4 (CD11c/CD18) are involved in complement-independent antibody-mediated phagocytosis of Cryptococcus neoformans. Immunity 2002;16:791-802.
32. Coxon A, Rieu P, Barkalow FJ, et al: A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation. Immunity 1996;5:653-666.
33. Serrander L, Larsson J, Lundqvist H, et al: Particles binding beta(2)-integrins mediate intracellular production of oxidative metabolites in human neutrophils independently of phagocytosis. Biochim Biophys Acta 1999;1452:133-144.
34. Luscinskas FW, Ma S, Nusrat A, Parkos CA, Shaw SK: The role of endothelial cell lateral junctions during leukocyte trafficking. Immunol Rev 2002;186:57-67.
35. Luscinskas FW, Ma S, Nusrat A, Parkos CA, Shaw SK: Leukocyte transendothelial migration: a junctional affair. Semin Immunol 2002;14:105-113.
36. Miyoshi EK, Stewart PL, Kincade PW, Lee MB, Thompson AA, Wall R: Aberrant expression and localization of the cytoskeleton-binding pp52 (LSP1) protein in hairy cell leukemia. Leuk Res 2001;25:57-67.
37. van Kooyk Y, Figdor CG: Avidity regulation of integrins: the driving force in leukocyte adhesion. Curr Opin Cell Biol 2000;12:542-547.
38. Defilippi P, Olivo C, Venturino M, Dolce L, Silengo L, Tarone G: Actin cytoskeleton organization in response to integrin-mediated adhesion. Microsc Res Tech 1999; 47:67-78.
39. Zu YL, Ai Y, Gilchrist A, Labadia ME, Sha'afi RI, Huang CK: Activation of MAP kinase-activated protein kinase 2 in human neutrophils after phorbol ester or fMLP peptide stimulation. Blood 1996;87:5287-5296.
40. Ohira T, Bannenberg G, Arita M, et al: A stable aspirin-triggered lipoxin A4 analog blocks phosphorylation of leukocyte-specific protein 1 in human neutrophils. J Immunol 2004;173:2091-2098.
41. Zu YL, Qi J, Gilchrist A, et al: p38 mitogen-activated protein kinase activation is required for human neutrophil function triggered by TNF-alpha or FMLP stimulation. J Immunol 1998;160:1982-1989.
42. Krump E, Sanghera JS, Pelech SL, Furuya W, Grinstein S: Chemotactic peptide N-formyl-met-leu-phe activation of p38 mitogen-activated protein kinase (MAPK) and MAPK-activated protein kinase-2 in human neutrophils. J Biol Chem 1997;272:937-944.
43. Hannigan MO, Zhan L, Ai Y, Kotlyarov A, Gaestel M, Huang CK: Abnormal migration phenotype of mitogen-activated protein kinase- activated protein kinase 2-/-neutrophils in Zigmond chambers containing formylmethionyl-leucyl- phenylalanine gradients. J Immunol 2001;167:3953-3961.
44. Tan SM, Hyland RH, Al-Shamkhani A, Douglass WA, Shaw JM, Law SK: Effect of integrin beta 2 subunit truncations on LFA-1 (CD11a/CD18) and Mac-1 (CD11b/CD18) assembly, surface expression, and function. J Immunol 2000;165:2574-2581.
45. Matsumoto N, Toyoshima S, Osawa T: Characterization of the 50 kDa protein phosphorylated in concanavalin A-stimulated mouse T cells. J Biochem (Tokyo) 1993; 113:630-636.
46. Matsumoto N, Kita K, Kojima S, et al: Lymphocyte isoforms of mouse p50 LSP1, which are phosphorylated in mitogen-activated T cells, are formed through alternative splicing and phosphorylation. J Biochem (Tokyo) 1995;118:237-243.
47. Carballo E, Colomer D, Vives-Corrons JL, Blackshear PJ, Gil J: Characterization and purification of a protein kinase C substrate in human B cells. Identification as lymphocyte-specific protein 1 (LSP1). J Immunol 1996; 156:1709-1713.
48. Harrison RE, Sikorski BA, Jongstra J: Leukocyte-specific protein 1 targets the ERK/MAP kinase scaffold protein KSR and MEK1 and ERK2 to the actin cytoskeleton. J Cell Sci 2004;117:2151-2157.
49. Ross GD: Regulation of the adhesion versus cytotoxic functions of the Mac-1/CR3/alphaMbeta2-integrin glycoprotein. Crit Rev Immunol 2000;20:197-222.
50. Jongstra-Bilen J, Harrison R, Grinstein S: Fcgamma-receptors induce Mac-1 (CD11b/CD18) mobilization and accumulation in the phagocytic cup for optimal phagocytosis. J Biol Chem 2003;278:45720-45729.
51. Qin H, Edberg JC, Gibson AW, Page GP, Teng L, Kimberly RP: Differential gene expression modulated by the cytoplasmic domain of Fc gamma RIa (CD64) alpha-chain. J Immunol 2004;173:6211-6219.